Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 7441 record(s)

Req # A-2024-000617

Adverse Drug Reactions (ADRs). Report numbers: E2B_07214947, E2B_07232555, E2B_07229289.

Organization: Health Canada

175 page(s)
January 2025

Req # A-2024-000637

Adverse Drug Reaction (ADR). Report number: 001082925.

Organization: Health Canada

8 page(s)
January 2025

Req # A-2024-000640

Adverse Drug Reactions (ADRs). Report numbers: E2B_07293904, E2B_07299064, E2B_07299072, E2B_07299655, E2B_07302023.

Organization: Health Canada

63 page(s)
January 2025

Req # A-2024-000668

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 24-102805-789, Exception to the Calculation of the Indigenous Target.

Organization: Health Canada

3 page(s)
January 2025

Req # A-2024-000677

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 24-104302-821, Information Technology Apprenticeship Program for Indigenous Peoples.

Organization: Health Canada

5 page(s)
January 2025

Req # A-2024-000688

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 24-100190-505, Update to the Health Canada Occupational Health and Safety Policy Committee Terms of Reference.

Organization: Health Canada

26 page(s)
January 2025

Req # A-2024-000699

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 24-105059-18, Health Canada’s 2024-27 Corporate Risk Profile.

Organization: Health Canada

83 page(s)
January 2025

Req # A-2024-000706

Adverse Drug Reactions (ADRs) for Leuprorelin. Report numbers: E2B_06985893, E2B_06463299, E2B_06478815, E2B_07089342, E2B_07139781, E2B_07091591, E2B_06698587, E2B_07133130, E2B_07044870, E2B_07041649.

Organization: Health Canada

79 page(s)
January 2025

Req # A-2024-000707

Adverse Drug Reactions (ADRs) for Leuprorelin. Report numbers: E2B_07035040, E2B_06899159, E2B_06926857, E2B_06836971, E2B_07168878, E2B_07119993, E2B_07248238, 001083465, E2B_07058290, E2B_07080809.

Organization: Health Canada

79 page(s)
January 2025

Req # A-2024-000710

Adverse Drug Reactions (ADRs) for Leuprorelin. Report numbers: E2B_06779053, E2B_06907444, E2B_07004123. ADRs for Leuprolide acetate. Report numbers: E2B_07148683, E2B_07154505, E2B_07148672, E2B_06868975, E2B_07148681.

Organization: Health Canada

122 page(s)
January 2025
Date modified: